Global Clinical Oncology Next Generation Sequencing (NGS) Market Research Report 2024(Status and Outlook)
Report Overview:
NGS allows the testing of all types of variants including single-nucleotide variations, insertions, deletions, exon duplications, gene copy number changes and translocations.
The Global Clinical Oncology Next Generation Sequencing (NGS) Market Size was estimated at USD 782.75 million in 2023 and is projected to reach USD 1432.70 million by 2029, exhibiting a CAGR of 10.60% during the forecast period.
This report provides a deep insight into the global Clinical Oncology Next Generation Sequencing (NGS) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Clinical Oncology Next Generation Sequencing (NGS) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Clinical Oncology Next Generation Sequencing (NGS) market in any manner.
Global Clinical Oncology Next Generation Sequencing (NGS) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Illumina
Roche
Agilent Technologies
Knome
Genomatix Software
GATC Biotech
Oxford Nanopore Technologies
Macrogen
Life Technologies
DNASTAR
Exosome Diagnostics
Biomatters
CLC Bio
BGI
Qiagen
Perkin Elmer
Pacific Bioscience
Partek
GnuBIO
Foundation Medicine
Paradigm
Caris Life Sciences
Myriad Genetics
Market Segmentation (by Type)
NGS Pre-Sequencing
Sequencing
NGS Data Analysis
Primary, Secondary & Tertiary Data Analysis
Market Segmentation (by Application)
Academic & Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Clinical Oncology Next Generation Sequencing (NGS) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
NGS allows the testing of all types of variants including single-nucleotide variations, insertions, deletions, exon duplications, gene copy number changes and translocations.
The Global Clinical Oncology Next Generation Sequencing (NGS) Market Size was estimated at USD 782.75 million in 2023 and is projected to reach USD 1432.70 million by 2029, exhibiting a CAGR of 10.60% during the forecast period.
This report provides a deep insight into the global Clinical Oncology Next Generation Sequencing (NGS) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Clinical Oncology Next Generation Sequencing (NGS) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Clinical Oncology Next Generation Sequencing (NGS) market in any manner.
Global Clinical Oncology Next Generation Sequencing (NGS) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Illumina
Roche
Agilent Technologies
Knome
Genomatix Software
GATC Biotech
Oxford Nanopore Technologies
Macrogen
Life Technologies
DNASTAR
Exosome Diagnostics
Biomatters
CLC Bio
BGI
Qiagen
Perkin Elmer
Pacific Bioscience
Partek
GnuBIO
Foundation Medicine
Paradigm
Caris Life Sciences
Myriad Genetics
Market Segmentation (by Type)
NGS Pre-Sequencing
Sequencing
NGS Data Analysis
Primary, Secondary & Tertiary Data Analysis
Market Segmentation (by Application)
Academic & Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Clinical Oncology Next Generation Sequencing (NGS) Market
- Overview of the regional outlook of the Clinical Oncology Next Generation Sequencing (NGS) Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Clinical Oncology Next Generation Sequencing (NGS) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Clinical Oncology Next Generation Sequencing (NGS)
1.2 Key Market Segments
1.2.1 Clinical Oncology Next Generation Sequencing (NGS) Segment by Type
1.2.2 Clinical Oncology Next Generation Sequencing (NGS) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET COMPETITIVE LANDSCAPE
3.1 Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Manufacturers (2019-2024)
3.2 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Manufacturers (2019-2024)
3.3 Clinical Oncology Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Clinical Oncology Next Generation Sequencing (NGS) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Clinical Oncology Next Generation Sequencing (NGS) Sales Sites, Area Served, Product Type
3.6 Clinical Oncology Next Generation Sequencing (NGS) Market Competitive Situation and Trends
3.6.1 Clinical Oncology Next Generation Sequencing (NGS) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Clinical Oncology Next Generation Sequencing (NGS) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) INDUSTRY CHAIN ANALYSIS
4.1 Clinical Oncology Next Generation Sequencing (NGS) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Type (2019-2024)
6.3 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2019-2024)
6.4 Global Clinical Oncology Next Generation Sequencing (NGS) Price by Type (2019-2024)
7 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Sales by Application (2019-2024)
7.3 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) by Application (2019-2024)
7.4 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Growth Rate by Application (2019-2024)
8 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET SEGMENTATION BY REGION
8.1 Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Region
8.1.1 Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Region
8.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Region
8.2 North America
8.2.1 North America Clinical Oncology Next Generation Sequencing (NGS) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Clinical Oncology Next Generation Sequencing (NGS) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Clinical Oncology Next Generation Sequencing (NGS) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Illumina
9.1.1 Illumina Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.1.2 Illumina Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.1.3 Illumina Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.1.4 Illumina Business Overview
9.1.5 Illumina Clinical Oncology Next Generation Sequencing (NGS) SWOT Analysis
9.1.6 Illumina Recent Developments
9.2 Roche
9.2.1 Roche Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.2.2 Roche Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.2.3 Roche Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.2.4 Roche Business Overview
9.2.5 Roche Clinical Oncology Next Generation Sequencing (NGS) SWOT Analysis
9.2.6 Roche Recent Developments
9.3 Agilent Technologies
9.3.1 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.3.2 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.3.3 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.3.4 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) SWOT Analysis
9.3.5 Agilent Technologies Business Overview
9.3.6 Agilent Technologies Recent Developments
9.4 Knome
9.4.1 Knome Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.4.2 Knome Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.4.3 Knome Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.4.4 Knome Business Overview
9.4.5 Knome Recent Developments
9.5 Genomatix Software
9.5.1 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.5.2 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.5.3 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.5.4 Genomatix Software Business Overview
9.5.5 Genomatix Software Recent Developments
9.6 GATC Biotech
9.6.1 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.6.2 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.6.3 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.6.4 GATC Biotech Business Overview
9.6.5 GATC Biotech Recent Developments
9.7 Oxford Nanopore Technologies
9.7.1 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.7.2 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.7.3 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.7.4 Oxford Nanopore Technologies Business Overview
9.7.5 Oxford Nanopore Technologies Recent Developments
9.8 Macrogen
9.8.1 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.8.2 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.8.3 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.8.4 Macrogen Business Overview
9.8.5 Macrogen Recent Developments
9.9 Life Technologies
9.9.1 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.9.2 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.9.3 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.9.4 Life Technologies Business Overview
9.9.5 Life Technologies Recent Developments
9.10 DNASTAR
9.10.1 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.10.2 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.10.3 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.10.4 DNASTAR Business Overview
9.10.5 DNASTAR Recent Developments
9.11 Exosome Diagnostics
9.11.1 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.11.2 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.11.3 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.11.4 Exosome Diagnostics Business Overview
9.11.5 Exosome Diagnostics Recent Developments
9.12 Biomatters
9.12.1 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.12.2 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.12.3 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.12.4 Biomatters Business Overview
9.12.5 Biomatters Recent Developments
9.13 CLC Bio
9.13.1 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.13.2 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.13.3 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.13.4 CLC Bio Business Overview
9.13.5 CLC Bio Recent Developments
9.14 BGI
9.14.1 BGI Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.14.2 BGI Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.14.3 BGI Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.14.4 BGI Business Overview
9.14.5 BGI Recent Developments
9.15 Qiagen
9.15.1 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.15.2 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.15.3 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.15.4 Qiagen Business Overview
9.15.5 Qiagen Recent Developments
9.16 Perkin Elmer
9.16.1 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.16.2 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.16.3 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.16.4 Perkin Elmer Business Overview
9.16.5 Perkin Elmer Recent Developments
9.17 Pacific Bioscience
9.17.1 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.17.2 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.17.3 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.17.4 Pacific Bioscience Business Overview
9.17.5 Pacific Bioscience Recent Developments
9.18 Partek
9.18.1 Partek Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.18.2 Partek Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.18.3 Partek Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.18.4 Partek Business Overview
9.18.5 Partek Recent Developments
9.19 GnuBIO
9.19.1 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.19.2 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.19.3 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.19.4 GnuBIO Business Overview
9.19.5 GnuBIO Recent Developments
9.20 Foundation Medicine
9.20.1 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.20.2 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.20.3 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.20.4 Foundation Medicine Business Overview
9.20.5 Foundation Medicine Recent Developments
9.21 Paradigm
9.21.1 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.21.2 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.21.3 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.21.4 Paradigm Business Overview
9.21.5 Paradigm Recent Developments
9.22 Caris Life Sciences
9.22.1 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.22.2 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.22.3 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.22.4 Caris Life Sciences Business Overview
9.22.5 Caris Life Sciences Recent Developments
9.23 Myriad Genetics
9.23.1 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.23.2 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.23.3 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.23.4 Myriad Genetics Business Overview
9.23.5 Myriad Genetics Recent Developments
10 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET FORECAST BY REGION
10.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast
10.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country
10.2.3 Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Region
10.2.4 South America Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Clinical Oncology Next Generation Sequencing (NGS) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Clinical Oncology Next Generation Sequencing (NGS) by Type (2025-2030)
11.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Clinical Oncology Next Generation Sequencing (NGS) by Type (2025-2030)
11.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Forecast by Application (2025-2030)
11.2.1 Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) Forecast by Application
11.2.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Clinical Oncology Next Generation Sequencing (NGS)
1.2 Key Market Segments
1.2.1 Clinical Oncology Next Generation Sequencing (NGS) Segment by Type
1.2.2 Clinical Oncology Next Generation Sequencing (NGS) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET COMPETITIVE LANDSCAPE
3.1 Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Manufacturers (2019-2024)
3.2 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Manufacturers (2019-2024)
3.3 Clinical Oncology Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Clinical Oncology Next Generation Sequencing (NGS) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Clinical Oncology Next Generation Sequencing (NGS) Sales Sites, Area Served, Product Type
3.6 Clinical Oncology Next Generation Sequencing (NGS) Market Competitive Situation and Trends
3.6.1 Clinical Oncology Next Generation Sequencing (NGS) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Clinical Oncology Next Generation Sequencing (NGS) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) INDUSTRY CHAIN ANALYSIS
4.1 Clinical Oncology Next Generation Sequencing (NGS) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Type (2019-2024)
6.3 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2019-2024)
6.4 Global Clinical Oncology Next Generation Sequencing (NGS) Price by Type (2019-2024)
7 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Sales by Application (2019-2024)
7.3 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) by Application (2019-2024)
7.4 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Growth Rate by Application (2019-2024)
8 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET SEGMENTATION BY REGION
8.1 Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Region
8.1.1 Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Region
8.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Region
8.2 North America
8.2.1 North America Clinical Oncology Next Generation Sequencing (NGS) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Clinical Oncology Next Generation Sequencing (NGS) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Clinical Oncology Next Generation Sequencing (NGS) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Illumina
9.1.1 Illumina Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.1.2 Illumina Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.1.3 Illumina Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.1.4 Illumina Business Overview
9.1.5 Illumina Clinical Oncology Next Generation Sequencing (NGS) SWOT Analysis
9.1.6 Illumina Recent Developments
9.2 Roche
9.2.1 Roche Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.2.2 Roche Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.2.3 Roche Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.2.4 Roche Business Overview
9.2.5 Roche Clinical Oncology Next Generation Sequencing (NGS) SWOT Analysis
9.2.6 Roche Recent Developments
9.3 Agilent Technologies
9.3.1 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.3.2 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.3.3 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.3.4 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) SWOT Analysis
9.3.5 Agilent Technologies Business Overview
9.3.6 Agilent Technologies Recent Developments
9.4 Knome
9.4.1 Knome Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.4.2 Knome Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.4.3 Knome Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.4.4 Knome Business Overview
9.4.5 Knome Recent Developments
9.5 Genomatix Software
9.5.1 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.5.2 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.5.3 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.5.4 Genomatix Software Business Overview
9.5.5 Genomatix Software Recent Developments
9.6 GATC Biotech
9.6.1 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.6.2 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.6.3 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.6.4 GATC Biotech Business Overview
9.6.5 GATC Biotech Recent Developments
9.7 Oxford Nanopore Technologies
9.7.1 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.7.2 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.7.3 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.7.4 Oxford Nanopore Technologies Business Overview
9.7.5 Oxford Nanopore Technologies Recent Developments
9.8 Macrogen
9.8.1 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.8.2 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.8.3 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.8.4 Macrogen Business Overview
9.8.5 Macrogen Recent Developments
9.9 Life Technologies
9.9.1 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.9.2 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.9.3 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.9.4 Life Technologies Business Overview
9.9.5 Life Technologies Recent Developments
9.10 DNASTAR
9.10.1 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.10.2 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.10.3 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.10.4 DNASTAR Business Overview
9.10.5 DNASTAR Recent Developments
9.11 Exosome Diagnostics
9.11.1 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.11.2 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.11.3 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.11.4 Exosome Diagnostics Business Overview
9.11.5 Exosome Diagnostics Recent Developments
9.12 Biomatters
9.12.1 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.12.2 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.12.3 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.12.4 Biomatters Business Overview
9.12.5 Biomatters Recent Developments
9.13 CLC Bio
9.13.1 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.13.2 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.13.3 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.13.4 CLC Bio Business Overview
9.13.5 CLC Bio Recent Developments
9.14 BGI
9.14.1 BGI Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.14.2 BGI Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.14.3 BGI Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.14.4 BGI Business Overview
9.14.5 BGI Recent Developments
9.15 Qiagen
9.15.1 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.15.2 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.15.3 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.15.4 Qiagen Business Overview
9.15.5 Qiagen Recent Developments
9.16 Perkin Elmer
9.16.1 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.16.2 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.16.3 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.16.4 Perkin Elmer Business Overview
9.16.5 Perkin Elmer Recent Developments
9.17 Pacific Bioscience
9.17.1 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.17.2 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.17.3 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.17.4 Pacific Bioscience Business Overview
9.17.5 Pacific Bioscience Recent Developments
9.18 Partek
9.18.1 Partek Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.18.2 Partek Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.18.3 Partek Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.18.4 Partek Business Overview
9.18.5 Partek Recent Developments
9.19 GnuBIO
9.19.1 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.19.2 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.19.3 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.19.4 GnuBIO Business Overview
9.19.5 GnuBIO Recent Developments
9.20 Foundation Medicine
9.20.1 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.20.2 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.20.3 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.20.4 Foundation Medicine Business Overview
9.20.5 Foundation Medicine Recent Developments
9.21 Paradigm
9.21.1 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.21.2 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.21.3 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.21.4 Paradigm Business Overview
9.21.5 Paradigm Recent Developments
9.22 Caris Life Sciences
9.22.1 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.22.2 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.22.3 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.22.4 Caris Life Sciences Business Overview
9.22.5 Caris Life Sciences Recent Developments
9.23 Myriad Genetics
9.23.1 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Basic Information
9.23.2 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product Overview
9.23.3 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product Market Performance
9.23.4 Myriad Genetics Business Overview
9.23.5 Myriad Genetics Recent Developments
10 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET FORECAST BY REGION
10.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast
10.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country
10.2.3 Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Region
10.2.4 South America Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Clinical Oncology Next Generation Sequencing (NGS) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Clinical Oncology Next Generation Sequencing (NGS) by Type (2025-2030)
11.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Clinical Oncology Next Generation Sequencing (NGS) by Type (2025-2030)
11.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Forecast by Application (2025-2030)
11.2.1 Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) Forecast by Application
11.2.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Clinical Oncology Next Generation Sequencing (NGS) Market Size Comparison by Region (M USD)
Table 5. Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Oncology Next Generation Sequencing (NGS) as of 2022)
Table 10. Global Market Clinical Oncology Next Generation Sequencing (NGS) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Clinical Oncology Next Generation Sequencing (NGS) Sales Sites and Area Served
Table 12. Manufacturers Clinical Oncology Next Generation Sequencing (NGS) Product Type
Table 13. Global Clinical Oncology Next Generation Sequencing (NGS) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Clinical Oncology Next Generation Sequencing (NGS)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Clinical Oncology Next Generation Sequencing (NGS) Market Challenges
Table 22. Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Type (K Units)
Table 23. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (M USD)
Table 24. Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) by Type (2019-2024)
Table 25. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Type (2019-2024)
Table 26. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) by Type (2019-2024)
Table 27. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Share by Type (2019-2024)
Table 28. Global Clinical Oncology Next Generation Sequencing (NGS) Price (USD/Unit) by Type (2019-2024)
Table 29. Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) by Application
Table 30. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
Table 31. Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Application (2019-2024) & (K Units)
Table 32. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Application (2019-2024)
Table 33. Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Application (2019-2024) & (M USD)
Table 34. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2019-2024)
Table 35. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Growth Rate by Application (2019-2024)
Table 36. Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Region (2019-2024) & (K Units)
Table 37. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Region (2019-2024)
Table 38. North America Clinical Oncology Next Generation Sequencing (NGS) Sales by Country (2019-2024) & (K Units)
Table 39. Europe Clinical Oncology Next Generation Sequencing (NGS) Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Sales by Region (2019-2024) & (K Units)
Table 41. South America Clinical Oncology Next Generation Sequencing (NGS) Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales by Region (2019-2024) & (K Units)
Table 43. Illumina Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 44. Illumina Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 45. Illumina Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Illumina Business Overview
Table 47. Illumina Clinical Oncology Next Generation Sequencing (NGS) SWOT Analysis
Table 48. Illumina Recent Developments
Table 49. Roche Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 50. Roche Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 51. Roche Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Roche Business Overview
Table 53. Roche Clinical Oncology Next Generation Sequencing (NGS) SWOT Analysis
Table 54. Roche Recent Developments
Table 55. Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 56. Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 57. Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) SWOT Analysis
Table 59. Agilent Technologies Business Overview
Table 60. Agilent Technologies Recent Developments
Table 61. Knome Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 62. Knome Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 63. Knome Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Knome Business Overview
Table 65. Knome Recent Developments
Table 66. Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 67. Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 68. Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Genomatix Software Business Overview
Table 70. Genomatix Software Recent Developments
Table 71. GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 72. GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 73. GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. GATC Biotech Business Overview
Table 75. GATC Biotech Recent Developments
Table 76. Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 77. Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 78. Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Oxford Nanopore Technologies Business Overview
Table 80. Oxford Nanopore Technologies Recent Developments
Table 81. Macrogen Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 82. Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 83. Macrogen Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Macrogen Business Overview
Table 85. Macrogen Recent Developments
Table 86. Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 87. Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 88. Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Life Technologies Business Overview
Table 90. Life Technologies Recent Developments
Table 91. DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 92. DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 93. DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. DNASTAR Business Overview
Table 95. DNASTAR Recent Developments
Table 96. Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 97. Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 98. Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Exosome Diagnostics Business Overview
Table 100. Exosome Diagnostics Recent Developments
Table 101. Biomatters Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 102. Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 103. Biomatters Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Biomatters Business Overview
Table 105. Biomatters Recent Developments
Table 106. CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 107. CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 108. CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. CLC Bio Business Overview
Table 110. CLC Bio Recent Developments
Table 111. BGI Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 112. BGI Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 113. BGI Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. BGI Business Overview
Table 115. BGI Recent Developments
Table 116. Qiagen Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 117. Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 118. Qiagen Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Qiagen Business Overview
Table 120. Qiagen Recent Developments
Table 121. Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 122. Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 123. Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Perkin Elmer Business Overview
Table 125. Perkin Elmer Recent Developments
Table 126. Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 127. Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 128. Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Pacific Bioscience Business Overview
Table 130. Pacific Bioscience Recent Developments
Table 131. Partek Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 132. Partek Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 133. Partek Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Partek Business Overview
Table 135. Partek Recent Developments
Table 136. GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 137. GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 138. GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. GnuBIO Business Overview
Table 140. GnuBIO Recent Developments
Table 141. Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 142. Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 143. Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Foundation Medicine Business Overview
Table 145. Foundation Medicine Recent Developments
Table 146. Paradigm Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 147. Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 148. Paradigm Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Paradigm Business Overview
Table 150. Paradigm Recent Developments
Table 151. Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 152. Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 153. Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. Caris Life Sciences Business Overview
Table 155. Caris Life Sciences Recent Developments
Table 156. Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 157. Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 158. Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. Myriad Genetics Business Overview
Table 160. Myriad Genetics Recent Developments
Table 161. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Region (2025-2030) & (K Units)
Table 162. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Region (2025-2030) & (M USD)
Table 163. North America Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Country (2025-2030) & (K Units)
Table 164. North America Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 165. Europe Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Country (2025-2030) & (K Units)
Table 166. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 167. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Region (2025-2030) & (K Units)
Table 168. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Region (2025-2030) & (M USD)
Table 169. South America Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Country (2025-2030) & (K Units)
Table 170. South America Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 171. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Consumption Forecast by Country (2025-2030) & (Units)
Table 172. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 173. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Type (2025-2030) & (K Units)
Table 174. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Type (2025-2030) & (M USD)
Table 175. Global Clinical Oncology Next Generation Sequencing (NGS) Price Forecast by Type (2025-2030) & (USD/Unit)
Table 176. Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) Forecast by Application (2025-2030)
Table 177. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Clinical Oncology Next Generation Sequencing (NGS) Market Size Comparison by Region (M USD)
Table 5. Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Oncology Next Generation Sequencing (NGS) as of 2022)
Table 10. Global Market Clinical Oncology Next Generation Sequencing (NGS) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Clinical Oncology Next Generation Sequencing (NGS) Sales Sites and Area Served
Table 12. Manufacturers Clinical Oncology Next Generation Sequencing (NGS) Product Type
Table 13. Global Clinical Oncology Next Generation Sequencing (NGS) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Clinical Oncology Next Generation Sequencing (NGS)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Clinical Oncology Next Generation Sequencing (NGS) Market Challenges
Table 22. Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Type (K Units)
Table 23. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (M USD)
Table 24. Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) by Type (2019-2024)
Table 25. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Type (2019-2024)
Table 26. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) by Type (2019-2024)
Table 27. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Share by Type (2019-2024)
Table 28. Global Clinical Oncology Next Generation Sequencing (NGS) Price (USD/Unit) by Type (2019-2024)
Table 29. Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) by Application
Table 30. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
Table 31. Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Application (2019-2024) & (K Units)
Table 32. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Application (2019-2024)
Table 33. Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Application (2019-2024) & (M USD)
Table 34. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2019-2024)
Table 35. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Growth Rate by Application (2019-2024)
Table 36. Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Region (2019-2024) & (K Units)
Table 37. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Region (2019-2024)
Table 38. North America Clinical Oncology Next Generation Sequencing (NGS) Sales by Country (2019-2024) & (K Units)
Table 39. Europe Clinical Oncology Next Generation Sequencing (NGS) Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Sales by Region (2019-2024) & (K Units)
Table 41. South America Clinical Oncology Next Generation Sequencing (NGS) Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales by Region (2019-2024) & (K Units)
Table 43. Illumina Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 44. Illumina Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 45. Illumina Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Illumina Business Overview
Table 47. Illumina Clinical Oncology Next Generation Sequencing (NGS) SWOT Analysis
Table 48. Illumina Recent Developments
Table 49. Roche Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 50. Roche Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 51. Roche Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Roche Business Overview
Table 53. Roche Clinical Oncology Next Generation Sequencing (NGS) SWOT Analysis
Table 54. Roche Recent Developments
Table 55. Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 56. Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 57. Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) SWOT Analysis
Table 59. Agilent Technologies Business Overview
Table 60. Agilent Technologies Recent Developments
Table 61. Knome Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 62. Knome Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 63. Knome Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Knome Business Overview
Table 65. Knome Recent Developments
Table 66. Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 67. Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 68. Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Genomatix Software Business Overview
Table 70. Genomatix Software Recent Developments
Table 71. GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 72. GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 73. GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. GATC Biotech Business Overview
Table 75. GATC Biotech Recent Developments
Table 76. Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 77. Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 78. Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Oxford Nanopore Technologies Business Overview
Table 80. Oxford Nanopore Technologies Recent Developments
Table 81. Macrogen Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 82. Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 83. Macrogen Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Macrogen Business Overview
Table 85. Macrogen Recent Developments
Table 86. Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 87. Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 88. Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Life Technologies Business Overview
Table 90. Life Technologies Recent Developments
Table 91. DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 92. DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 93. DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. DNASTAR Business Overview
Table 95. DNASTAR Recent Developments
Table 96. Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 97. Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 98. Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Exosome Diagnostics Business Overview
Table 100. Exosome Diagnostics Recent Developments
Table 101. Biomatters Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 102. Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 103. Biomatters Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Biomatters Business Overview
Table 105. Biomatters Recent Developments
Table 106. CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 107. CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 108. CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. CLC Bio Business Overview
Table 110. CLC Bio Recent Developments
Table 111. BGI Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 112. BGI Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 113. BGI Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. BGI Business Overview
Table 115. BGI Recent Developments
Table 116. Qiagen Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 117. Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 118. Qiagen Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Qiagen Business Overview
Table 120. Qiagen Recent Developments
Table 121. Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 122. Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 123. Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Perkin Elmer Business Overview
Table 125. Perkin Elmer Recent Developments
Table 126. Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 127. Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 128. Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Pacific Bioscience Business Overview
Table 130. Pacific Bioscience Recent Developments
Table 131. Partek Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 132. Partek Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 133. Partek Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Partek Business Overview
Table 135. Partek Recent Developments
Table 136. GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 137. GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 138. GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. GnuBIO Business Overview
Table 140. GnuBIO Recent Developments
Table 141. Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 142. Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 143. Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Foundation Medicine Business Overview
Table 145. Foundation Medicine Recent Developments
Table 146. Paradigm Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 147. Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 148. Paradigm Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Paradigm Business Overview
Table 150. Paradigm Recent Developments
Table 151. Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 152. Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 153. Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. Caris Life Sciences Business Overview
Table 155. Caris Life Sciences Recent Developments
Table 156. Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Basic Information
Table 157. Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product Overview
Table 158. Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. Myriad Genetics Business Overview
Table 160. Myriad Genetics Recent Developments
Table 161. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Region (2025-2030) & (K Units)
Table 162. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Region (2025-2030) & (M USD)
Table 163. North America Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Country (2025-2030) & (K Units)
Table 164. North America Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 165. Europe Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Country (2025-2030) & (K Units)
Table 166. Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 167. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Region (2025-2030) & (K Units)
Table 168. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Region (2025-2030) & (M USD)
Table 169. South America Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Country (2025-2030) & (K Units)
Table 170. South America Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 171. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Consumption Forecast by Country (2025-2030) & (Units)
Table 172. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 173. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Type (2025-2030) & (K Units)
Table 174. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Type (2025-2030) & (M USD)
Table 175. Global Clinical Oncology Next Generation Sequencing (NGS) Price Forecast by Type (2025-2030) & (USD/Unit)
Table 176. Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) Forecast by Application (2025-2030)
Table 177. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Clinical Oncology Next Generation Sequencing (NGS)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD), 2019-2030
Figure 5. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) (2019-2030)
Figure 6. Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (M USD)
Figure 11. Clinical Oncology Next Generation Sequencing (NGS) Sales Share by Manufacturers in 2023
Figure 12. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Manufacturers in 2023
Figure 13. Clinical Oncology Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Clinical Oncology Next Generation Sequencing (NGS) Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Clinical Oncology Next Generation Sequencing (NGS) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type
Figure 18. Sales Market Share of Clinical Oncology Next Generation Sequencing (NGS) by Type (2019-2024)
Figure 19. Sales Market Share of Clinical Oncology Next Generation Sequencing (NGS) by Type in 2023
Figure 20. Market Size Share of Clinical Oncology Next Generation Sequencing (NGS) by Type (2019-2024)
Figure 21. Market Size Market Share of Clinical Oncology Next Generation Sequencing (NGS) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application
Figure 24. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Application (2019-2024)
Figure 25. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Application in 2023
Figure 26. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2019-2024)
Figure 27. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application in 2023
Figure 28. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Region (2019-2024)
Figure 30. North America Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Country in 2023
Figure 32. U.S. Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Clinical Oncology Next Generation Sequencing (NGS) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Country in 2023
Figure 37. Germany Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Region in 2023
Figure 44. China Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (K Units)
Figure 50. South America Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Country in 2023
Figure 51. Brazil Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share Forecast by Type (2025-2030)
Figure 65. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Application (2025-2030)
Figure 66. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Clinical Oncology Next Generation Sequencing (NGS)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD), 2019-2030
Figure 5. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (M USD) (2019-2030)
Figure 6. Global Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Clinical Oncology Next Generation Sequencing (NGS) Market Size by Country (M USD)
Figure 11. Clinical Oncology Next Generation Sequencing (NGS) Sales Share by Manufacturers in 2023
Figure 12. Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Manufacturers in 2023
Figure 13. Clinical Oncology Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Clinical Oncology Next Generation Sequencing (NGS) Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Clinical Oncology Next Generation Sequencing (NGS) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type
Figure 18. Sales Market Share of Clinical Oncology Next Generation Sequencing (NGS) by Type (2019-2024)
Figure 19. Sales Market Share of Clinical Oncology Next Generation Sequencing (NGS) by Type in 2023
Figure 20. Market Size Share of Clinical Oncology Next Generation Sequencing (NGS) by Type (2019-2024)
Figure 21. Market Size Market Share of Clinical Oncology Next Generation Sequencing (NGS) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application
Figure 24. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Application (2019-2024)
Figure 25. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Application in 2023
Figure 26. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2019-2024)
Figure 27. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application in 2023
Figure 28. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Region (2019-2024)
Figure 30. North America Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Country in 2023
Figure 32. U.S. Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Clinical Oncology Next Generation Sequencing (NGS) Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Clinical Oncology Next Generation Sequencing (NGS) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Country in 2023
Figure 37. Germany Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Region in 2023
Figure 44. China Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (K Units)
Figure 50. South America Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Country in 2023
Figure 51. Brazil Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Clinical Oncology Next Generation Sequencing (NGS) Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share Forecast by Type (2025-2030)
Figure 65. Global Clinical Oncology Next Generation Sequencing (NGS) Sales Forecast by Application (2025-2030)
Figure 66. Global Clinical Oncology Next Generation Sequencing (NGS) Market Share Forecast by Application (2025-2030)
